HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,517,108 | +5.2% | 28,099 | 0.0% | 0.01% | +12.5% |
Q2 2023 | $2,392,349 | +2.9% | 28,099 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $2,325,192 | +5.2% | 28,099 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $2,209,986 | -5.7% | 28,099 | -11.2% | 0.01% | -11.1% |
Q3 2022 | $2,343,000 | -6.1% | 31,647 | -17.4% | 0.01% | 0.0% |
Q2 2022 | $2,496,000 | -13.2% | 38,296 | -15.8% | 0.01% | 0.0% |
Q1 2022 | $2,876,000 | +8.4% | 45,494 | -9.0% | 0.01% | +12.5% |
Q4 2021 | $2,652,000 | -17.6% | 50,002 | +9.6% | 0.01% | -20.0% |
Q3 2021 | $3,220,000 | +9.9% | 45,622 | +3.8% | 0.01% | 0.0% |
Q2 2021 | $2,929,000 | -19.0% | 43,951 | +35.0% | 0.01% | -23.1% |
Q1 2021 | $3,615,000 | -12.8% | 32,563 | -6.7% | 0.01% | -13.3% |
Q4 2020 | $4,144,000 | +30.2% | 34,896 | -4.4% | 0.02% | +15.4% |
Q3 2020 | $3,184,000 | -5.1% | 36,490 | -2.6% | 0.01% | -7.1% |
Q2 2020 | $3,354,000 | -18.9% | 37,449 | -9.7% | 0.01% | -30.0% |
Q1 2020 | $4,134,000 | -13.3% | 41,477 | 0.0% | 0.02% | +11.1% |
Q4 2019 | $4,766,000 | -14.7% | 41,477 | -6.4% | 0.02% | -18.2% |
Q3 2019 | $5,588,000 | – | 44,300 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |